News update
Blog archive
-
Bücker R (2025) Editorial: Therapeutic and protective approaches to gastrointestinal
tract infections.
Front Pharmacol. 16: 1650144 (3 pages). doi: 10.3389/fphar.2025.165014
(°IF 4.8)
-
Mousa SA, Hong X, Metwally EY, Tafelski S, Wandrey JD, Piontek J, Treskatsch S, Schäfer M, Shaqura M
(2025) Components of mineralocorticoid receptor system in human DRG neurons co-expressing pain-signaling molecules: implications for nociception.
Cells
14: 1142 (14 pages). doi: 10.3390/cells14151142
(°IF 5.2) -
Bachus A, Beyer S, Bücker R, Sharbati S, Alter T, Gölz G (2025) Pathogenicity of Arcobacter cryaerophilus in two human intestinal cell lines.
Gut Pathog.
17(1): 48 (13 pages). doi: 10.1186/s13099-025-00721-4
(°IF 4.0) -
Hagen KD, Nosala C, Müller A, Hilton NA, Holthaus D, Schulzke JD, Krug SM, Hoffmann T, Laue M,
Klotz C, Aebischer A, Dawson SC (2025) Giardia's domed ventral disc architecture is essential for attachment and contributes to epithelial barrier disruption.
Mol. Biol. Cell
36(8): ar93.
doi: 10.1091/mbc.E23-12-0515
(°IF 2.7)-
Rosenthal R, Waesch A, Masete KV, Massarani AS, Schulzke JD, Hering
NA (2025) The green tea component (-)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells.
Front. Pharmacol.
16: 1559812 (12 pages) doi: 10.3389/fphar.2025.1559812
(°IF 4.8)
-
Atalla MS, Bettenhausen A-L, Verse JM, Cebulla N, Krug SM, Sauer R-S, Srivastava M, Bischler T, Chen JTC, Kortüm KM, Kittel RJ, Sommer C, Rittner HL (2025) Neuronal toxicity and recovery from
early bortezomib-induced neuropathy: blood nerve barrier dysfunction without dorsal root ganglion damage.
Br. J. Anaesth.
(online ahead of print) S0007-0912(25)00366-6 (12 pages). doi:
10.1016/j.bja.2025.05.046 (°IF 9.2)
-
Krug SM*, Lee IM*, Knobe L* (*shared first authorship), Hartmannsberger B, Atalla MS, Rittner HL, Fromm M (2025) Characterising epi-perineurial barrier function
by microscale techniques including a miniaturised
Ussing chamber. Acta Biomater. 199: 290-300. doi: 10.1016/j.actbio.2025.04.043
(°IF 9.6)
|
